CollPlant Biotechnologies Ltd (CLGN)
5.95
-0.24
(-3.80%)
USD |
NASDAQ |
May 03, 16:00
6.00
+0.05
(+0.84%)
After-Hours: 20:00
CollPlant Biotechnologies Profit Margin (Quarterly): -1.57K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.57K% |
| September 30, 2023 | -10.18K% |
| June 30, 2023 | 56.58% |
| March 31, 2023 | -858.0% |
| December 31, 2022 | -7.59K% |
| September 30, 2022 | -4.02K% |
| June 30, 2022 | -6.49K% |
| March 31, 2022 | -5.85K% |
| December 31, 2021 | -1.22K% |
| September 30, 2021 | -2.20K% |
| June 30, 2021 | -439.7% |
| March 31, 2021 | 69.82% |
| December 31, 2020 | -521.5% |
| September 30, 2020 | 16.95% |
| June 30, 2020 | -239.5% |
| Date | Value |
|---|---|
| March 31, 2020 | -262.9% |
| December 31, 2019 | -1.02K% |
| September 30, 2019 | -467.9% |
| June 30, 2019 | -205.9% |
| March 31, 2019 | -377.1% |
| December 31, 2018 | -29.34% |
| September 30, 2018 | -589.7% |
| June 30, 2018 | -851.1% |
| March 31, 2018 | -929.8% |
| December 31, 2017 | -695.9% |
| September 30, 2017 | -1.49K% |
| June 30, 2017 | -2.91K% |
| March 31, 2017 | -2.06K% |
| December 31, 2016 | -3.31K% |
| September 30, 2016 | -7.43K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.18K%
Minimum
Sep 2023
69.82%
Maximum
Mar 2021
-2.26K%
Average
-858.0%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 29.03% |
| Pluri Inc | -4.67K% |
| BioLine Rx Ltd | -289.2% |
| Can Fite Biofarma Ltd | -1.07K% |
| BiomX Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.08% |
| Return on Assets | -18.79% |
| Return on Invested Capital | -22.08% |
| Gross Profit Margin (Quarterly) | -158.5% |
| Operating Margin (Quarterly) | -1.69K% |
| Return on Net Operating Assets | -68.45% |